; and (B) any other country that benefits from the near-shoring of the production of a product identified under subsection (b)(1)(B) to the country. (2) Prioritization of pharmaceuticals In carrying out the process described in paragraph (1), the Secretary shall begin with regulatory alignment with respect to pharmaceuticals. (3) Reports required The Secretary shall submit to Congress and make available to the public reports on the success of efforts under paragraph (1) on a continuous basis. (f) United States International Development Finance Corporation (1) In general For purposes of supporting near-shoring of strategic supply chains to Americas partner countries and such other countries as the President considers appropriate, the United States International Development Finance Corporation (in this subsection referred to as the Corporation ) may provide support under title II of the Better Utilization of Investments Leading to Development Act of 2018 ( 22 U.S.C. 9621 et seq. ) to countries with upper-middle-income economies or high-income economies (as those terms are defined by the World Bank) without regard to the limitation under section 1412(c)(2) of that Act ( 22 U.S.C. 9612(c)(2) ). (2) Limitations The Corporation shall restrict the provision of support to a country described in paragraph (1) unless— (A) the President certifies to the appropriate congressional committees (as defined in section 1402 of the Better Utilization of Investments Leading to Development Act of 2018 ( 22 U.S.C. 9601 )) that such support furthers the national economic or foreign policy interests of the United States; and (B) such support is— (i) designed to support the development of strategic supply chains in countries other than the People's Republic of China